Cresco Labs Inc

What Is The Trump Factor? Justice Dept's Impact On Cannabis Rescheduling, Stocks And Investments

Normalizing & Professionalizing Cannabis With Cresco Labs' CEO Charlie Bachtell

From Fast-Acting Hemp Extracts To Wiz Khalifa Mushroom Kits: Tracking Progressive Trends In Cannabis & Psychedelics

Normalizing & Professionalizing Cannabis With Cresco Labs' CEO Charlie Bachtell

From Fast-Acting Hemp Extracts To Wiz Khalifa Mushroom Kits: Tracking Progressive Trends In Cannabis & Psychedelics

Inclusion Ignites Illinois Marijuana Industry: New Ventures Rise As Benzinga's Cannabis Conference Hits Chicago

Employee Poaching Controversy Heats Up Among Top US Cannabis Companies

Inclusion Ignites Illinois Marijuana Industry: New Ventures Rise As Benzinga's Cannabis Conference Hits Chicago

Employee Poaching Controversy Heats Up Among Top US Cannabis Companies

Cannabis Retail Prices In Illinois Decrease 18% YoY, Cantor Fitzgerald Survey Looks Into Why

Missouri Recreational Marijuana Sales And Their Impact On Illinois' Market, An Expert's View

Cresco Labs Inc Recent News

These Are The Largest Cannabis Companies In Chicago, According To Crain's

On Monday, Crain's Chicago released a list of Chicago's largest marijuana companies.

Cresco Labs Gains 'Firm Visibility' With Recent Asset Sales To Sean Diddy Combs

Cresco Labs Inc (OTCMKTS: CRLBF) and Columbia Care Inc (OTCMKTS: CCHWF) announced the signing of definitive agreements to divest certain New York, Illinois, and Massachusetts assets to an entity owned and controlled by

Cresco Lab's 1Q Results After Conference Call, Analyst Opines

The Analyst Following Cresco Labs’ (OTC: CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.

Columbia Care: Challenging 1Q, Stock Is Now Tied to Cresco Deal Analyst Says

The Analyst Pablo Zuanic, from Cantor Fitzgerald, rated Columbia Care Inc. (OTC: CCHWF) as Overweight with a price target of $5.10.

Cresco Labs To Acquire Columbia Care For $2.1B, Becoming Largest Cannabis Company In US

Low-Cost Pot Stocks To Consider, According To Entourage Effect Capital's Codie Sanchez

There are several key parameters an investor should consider when investing in the cannabis space, according to Entourage Effect Capital (EEC) Managing Director Codie Sanchez.

Adequate Implementation, Not Additional Taxes, Key To Cannabis Social Equity Success

The calls for social equity in cannabis continue to grow louder as the market matures and more states come online. While most in the space support social equity, its implementation and the market's taxation has the sector debating the need for high taxes to fund equitable efforts.

How Many Legal Weed States Before We Get Federal Reform? We May Be There Already

Most states have passed some type of cannabis reform — only six consider it fully illegal. Yet, on the federal level, the marijuana prohibition has yet to be repealed. Lawmakers continue to drag their feet, with just incremental progress taking shape in the 116th Congress.

Cannabis SPACs Will Remain Popular In 2021 Despite Several Challenges

Cannabis companies continue to face restrictions on most national exchanges. Special-purpose acquisition companies (SPACs) help fill the funding void. These types of deals are occurring more often as a less costly and more efficient go-public strategy.

Home Cannabis Cultivation Continues, Despite Opposition From Many Marijuana Companies

Home cultivation has emerged as a clear sticking point in cannabis reform across many states. While it faces pushback, including from several cannabis brands, home grow is making incremental progress in medical and adult use markets, and ushering in a variety of parameters to meet state needs.

Cresco Labs CEO Discusses Cannabis Industry Challenges, Reaching Nationwide Customer Base

The main thing holding the cannabis industry back is access to capital, according to Cresco Labs Inc (OTCQX: CRLBF) CEO Charlie Bachtell.